DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



New Type of a Pancreaticojejunostomy

Information source: University of Tampere
Information obtained from ClinicalTrials.gov on November 03, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Pancreaticojejunostomy After Pancreatic Head Resection

Intervention: Pancreaticojejunostomy without stiches through the pancreas (Procedure)

Phase: Phase 1

Status: Recruiting

Sponsored by: University of Tampere

Official(s) and/or principal investigator(s):
Isto H Nordback, M.D., Principal Investigator, Affiliation: TampereUH

Overall contact:
Isto H Nordback, M.D., Phone: +358-3-31164608, Email: isto.nordback@pshp.fi

Summary

Previously we have demonstrated in animal experiments,that pancreas is extremely vulnerable to handling, reacting with the development of pancreatitis. In human pancreatic surgery, post-operative pancreatitis mediates many other post-operative complications. A new anastomosis was developed to diminish the injury, as being without any stitches going through the pancreas. The aims were to study up to 30 patients as phase one study, with an interim analysis in this open uncontrolled trial after the first few patients.

Clinical Details

Official title: New Type of a Pancreaticojejunostomy - a Pilot Study

Study design: Treatment, Open Label, Uncontrolled, Single Group Assignment, Safety Study

Primary outcome: Pancreatic fistula, other complications

Secondary outcome: Patency of the pancreaticojejunostomy

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Patients scheduled to undergo peancreatic head resection

Exclusion Criteria:

- Those who refuse from the study

Locations and Contacts

Isto H Nordback, M.D., Phone: +358-3-31164608, Email: isto.nordback@pshp.fi

Tampere University Hospital, Tampere 33520, Finland; Recruiting
Erkki Wuolijoki, Director of the research unit, Phone: +358-3-31169130, Email: erkki.wuolijoki@pshp.fi
Isto H Nordback, M.D., Principal Investigator
Additional Information

Starting date: December 2006
Last updated: June 9, 2008

Page last updated: November 03, 2008

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009